Literature DB >> 6813564

Mineral metabolism during prolonged oral calcium substitution after jejuno-ileal bypass for morbid obesity.

D Scholz, P O Schwille, B Husemann, T Herzog, H W Schley, C Morzinietz, A Sigel.   

Abstract

The influence of jejuno-ileal bypass surgery on mineral metabolism was studied in patients with morbid obesity before operation, and 2 and 5 years after-wards. When calcium and potassium were orally substituted post-operatively, in serum calcium fractions, parathyroid hormone, phosphate, potassium and the bone mineral content remained unchanged, while serum magnesium decreased. Serum 25-hydroxyvitamin D was already low before bypass operation, and did not change thereafter. Post-operatively, the urinary excretion of oxalate rose into the upper normal range, while that of calcium, magnesium and citrate was markedly reduced. The urinary activity product of calcium oxalate rose slightly, but that of brushite decreased. Since these changes were manifest in the urine of all patients, the reasons for the post-operative formation of renal stones in 4 of 19 patients remain unclear at the moment. We conclude that the recommendation for precise oral calcium substitution after jejuno-ileal bypass operation seems justified in order to avoid serious disturbances of calcium metabolism in the long term, and to reduce intestinal oxalate absorption.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813564     DOI: 10.1007/bf01721145

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  18 in total

1.  Metabolic intestinal surgery. Its complications and management.

Authors:  G B Starkloff; J F Donovan; K R Ramach; B M Wolfe
Journal:  Arch Surg       Date:  1975-05

2.  Oxalate stone disease after intestinal resection.

Authors:  J G Gregory; K Y Park; H W Schoenberg
Journal:  J Urol       Date:  1977-05       Impact factor: 7.450

3.  Urinary tract stone after small bowel bypass for morbid obesity.

Authors:  J P O'Leary; W C Thomas; E R Woodward
Journal:  Am J Surg       Date:  1974-02       Impact factor: 2.565

4.  Activity products in stone-forming and non-stone-forming urine.

Authors:  W G Robertson; M Peacock; B E Nordin
Journal:  Clin Sci       Date:  1968-06       Impact factor: 6.124

5.  Bone disease after jejuno-ileal bypass for obesity.

Authors:  J E Compston; L W Horton; M F Laker; A B Ayers; J S Woodhead; H J Bull; J C Gazet; T R Pilkington
Journal:  Lancet       Date:  1978-07-01       Impact factor: 79.321

6.  Randomised trial of jejunoileal bypass versus medical treatment in morbid obesity. The Danish Obesity Project.

Authors: 
Journal:  Lancet       Date:  1979-12-15       Impact factor: 79.321

7.  25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man.

Authors:  S B Arnaud; R S Goldsmith; P W Lambert; V L Go
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

8.  Hypocitraturia in patients with gastrointestinal malabsorption.

Authors:  D Rudman; J L Dedonis; M T Fountain; J B Chandler; G G Gerron; G A Fleming; M H Kutner
Journal:  N Engl J Med       Date:  1980-09-18       Impact factor: 91.245

9.  Effect of magnesium deficiency on rat bone and kidney sensitivity to parathyroid hormone.

Authors:  R M Forbes; H M Parker
Journal:  J Nutr       Date:  1980-08       Impact factor: 4.798

10.  Calcium malabsorption and absence of bone decalcination following intestinal shunt operation for obesity. A comparison of two types of operation.

Authors:  P Danö; C Christiansen
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

View more
  3 in total

1.  Morbid obesity--surgical treatment--when and how?

Authors:  H Buchwald; B Husemann; A F Leutenegger; E E Mason; M Rothmund; J R Siewert
Journal:  Langenbecks Arch Chir       Date:  1986

Review 2.  Open-surgery management of morbid obesity: old experience-new techniques.

Authors:  Bernhard Husemann
Journal:  Langenbecks Arch Surg       Date:  2003-11-04       Impact factor: 3.445

Review 3.  Hyperoxaluria after modern bariatric surgery: case series and literature review.

Authors:  Jared M Whitson; G Bennett Stackhouse; Marshall L Stoller
Journal:  Int Urol Nephrol       Date:  2009-07-02       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.